ñ²ðï¼´Ë׳ƵÄÑò½Ç·ç»òÑòñ²·ç£¬ÊǶàÖÖÔÒòÒýÆðÄÔ²¿Éñ¾ÔªÈºÕó·¢ÐÔÒì³£·ÅµçËùÖµķ¢×÷ÐÔÔ˶¯¡¢¸Ð¾õ¡¢Òâʶ¡¢¾«Éñ¡¢Ö²ÎïÉñ¾¹¦ÄÜÒì³£µÄÒ»ÖÖ¼²²¡¡£¾ÝÖйú×îÐÂÁ÷Ðв¡Ñ§×ÊÁÏÏÔʾ£¬¹úÄÚñ²ðïµÄ×ÜÌ廼²¡ÂÊΪ7.0‰£¬Äê·¢²¡ÂÊΪ28.8/ 10 Íò£¬1ÄêÄÚÓз¢×÷µÄ»î¶¯ÐÔñ²ðﻼ²¡ÂÊΪ4.6‰¡£
ÐÂƤ²ãñ²ðïÊÇÒ»ÖÖÖ¢×´ÐÔ(»ò¿ÉÄÜΪ֢״ÐÔµÄ)¾ÖÔîÐÔñ²ðï¡£ñ²ðïÍâ¿ÆÊÇÖÎÁÆÄÑÖÎÐÔñ²ðïµÄÓÐЧÖÎÁÆÊֶΣ¬ÓÈÆäÊÇò¨Ò¶ñ²ðÍâ¿ÆÊÖÊõÊÇ×î¼ÑµÄÑ¡Ôñ¡£µ«ÐµĿ¹ñ²ðïÒ©ÎïµÄЧ¹û¸üÎȶ¨£¬¸üÓÐЧ£¬Òò´ËÄ¿Ç°ò¨Ò****************Ú²àÐÍñ²ðïÍâ¿ÆÊÖÊõµÄÁ¿ÔÚ²»¶ÏϽµ£¬¼´±ãÈç´Ë£¬·ÇƤËðÐÍÐÂƤ²ãñ²ðïµÄÊÖÊõ±ÈÀýÈ´ÓÐËùÔö¼Ó¡£È»¶ø£¬Ö»ÓÐÉÙÊýµÄÑо¿Ì½¾¿ÁË·ÇƤËðÐÍÐÂƤ²ãñ²ðïÍâ¿ÆÖÎÁƵij¤ÆÚÔ¤ºóºÍDZÔÚÔ¤ºóÒòËØ¡£
±¾ÔÂ3ÈÕ£¬JAMA NeurolÉÏ¿¯µÇÁËһƪÑо¿£¬¸ÃÑо¿ÆÀ¹ÀÁË·ÇƤËðÐÍÐÂƤ²ãñ²ðﻼÕߵij¤ÆÚÍâ¿ÆÊÖÊõÔ¤ºó²¢È·¶¨ÁË¿ÉÄܵÄÔ¤ºóÒòËØ¡£
À´×Ôº«¹úµÄÑо¿ÈËÔ±¶Ô109ÀýÔÚ1995.9-2005.12¼äµÄÊ׶û¹úÁ¢´óѧ¸½ÊôÒ½ÔºÐоÖÔîÐÔÇгýÊõµÄÒ©ÎïÄÑÖÎÐÔÐÂƤ²ãñ²ðﻼÕß(´Å¹²Õñ³ÉÏñÏÔʾÎÞƤËð)½øÐÐÁ˶ÓÁÐÑо¿£¬Ëæ·ÃÖÁÉÙ10Ä꣬µ«ÓÐ1Àý³ýÍâ¡£
Ñо¿ÈËԱͨ¹ýµ¥ÒòËغͱê×¼»¯¶àÔªlogistic»Ø¹é·ÖÎöÒÔÈ·¶¨Íâ¿ÆÊÖÊõÁÆЧµÄÔ¤²âÒò×Ó£¬²¢Í¨¹ýÒ»¸ö¹ãÒå¹À¼Æ·½³ÌµÄÄ£ÐͶԳ¤´ï21ÄêµÄËæ·Ã½øÐÐ×ÝÏò¶àÔªlogistic»Ø¹é·ÖÎö¡£
Ñо¿ÈËÔ±·¢ÏÖ£ºÔÚ64ÃûÄÐÐÔºÍ45ÃûÅ®ÐÔ»¼ÕßÖУ¬»¼ÕßµÄÊÖÊõÄêÁ䷶Χ´Ó7Ëêµ½56Ëê(ƽ¾ùSD£¬27.1 [7.8]Äê)¡£ÔÚÊõºóµÚÒ»ÄêËæ·Ãʱ£¬109Àý»¼ÕßÖÐÓÐ59Àý(54.1%)»¼ÕßÎÞñ²ðï·¢×÷;ÔÚ×îÖÕËæ·ÃÖУ¬108Àý»¼ÕßÖеÄ64Àý(59.3%)»¼ÕßÎÞñ²ðï·¢×÷¡£108Àý»¼ÕßÖÐÖ»ÓÐ(10.2%)11Àý»¼ÕßÊõºóñ²ð︴·¢¡£¹¦ÄÜÐÔÉñ¾Ó°ÏñµÄ¶¨Î»Ä£Ê½(·úÍÑÑõÆÏÌÑÌÇÕýµç×Ó·¢Éä¶Ï²ãɨÃèʱ£¬×îÇ¿OR£¬0.30 [ 95%CI£¬0.14-0.66];·¢×÷ÆÚµ¥¹â×Ó·¢Éä¼ÆËã»ú¶Ï²ãɨÃèʱ£¬×îÇ¿OR£¬0.37 [ 95% CI£¬0.15-0.87 ])£¬ÊõÇ°Õï¶ÏÆÀ¹ÀµÄ½á¹û(OR£¬3.15 [ 95% CI£¬1.42-7.02 ])£¬¹â»·µÄ´æÔÚ(»ò£¬3.49 [ 95% CI£¬1.54-7.92 ])£¬ºÍÂÄÚÄÔµçͼÑо¿¹ý³ÌÖÐƵ·±·¢×÷µÄ¼â·åÇøËù¶ÔÓ¦µÄ·¢×÷ÇøÓòµÄÍêÈ«Çгý(»ò0.37 [ 95% CI£¬0.16-0.85 ])ÊÇÁ¼ºÃµÄÊÖÊõÔ¤ºóµÄÔ¤ºóÒòËØ¡£
¸ÃÑо¿½á¹û±íÃ÷£¬½ü60%µÄ·ÇƤËðÐÍÐÂƤ²ãñ²ðﻼÕß¾¹ýÍâ¿ÆÖÎÁÆ°ÚÍÑÁ˳¤ÆÚµÄñ²ðï·¢×÷״̬£¬¶øÇÒ¸´·¢µÄÇé¿öºÜÉÙ¡£¸ÃÑо¿»¹È·¶¨Á˼¸¸öÓÐÀûÓÚÍâ¿ÆÊÖÊõÔ¤ºóµÄÔ¤ºóÒòËØ£¬Õ⽫ÓÐÖúÓÚÒ½ÉúÅжϷÇƤËðÐÍÐÂƤ²ãñ²ðﻼÕßÊÇ·ñÊʺÏÊÖÊõÖÎÁÆ¡£
Ôʼ³ö´¦£º
Kim DW, Lee SK£¬et al.Surgical Treatment of Nonlesional Neocortical Epilepsy: Long-term Longitudinal Study.JAMA Neurol. 2017 Jan 3.